Isomorphic Labs, a DeepMind spinoff focusing on drug discovery, raised $600M led by Thrive to research treatments, including for cancer and immune disorders (Michael J. de la Merced/New York Times)

by #AI [2.0] March 31, 2025 · Automatic / Editor's Picks [News]

Michael J. de la Merced / New York Times:
Isomorphic Labs, a DeepMind spinoff focusing on drug discovery, raised $600M led by Thrive to research treatments, including for cancer and immune disorders — The company, which uses artificial intelligence to develop new treatments, now counts the venture capital firm Thrive Capital as a backer.